Different phospholipid transfer protein complexes contribute to the variation in plasma PLTP specific activity.

Biochim Biophys Acta

Division of Metabolism, Endocrinology and Nutrition, Northwest Lipid Metabolism and Diabetes Research Laboratories, Department of Medicine, University of Washington, Seattle, WA 98109-4517, USA.

Published: May 2011

Phospholipid transfer protein (PLTP) facilitates the transfer of phospholipids among lipoproteins. Over half of the PLTP in human plasma has been found to have little phospholipid transfer activity (inactive PLTP). We recently observed that plasma PLTP specific activity is inversely correlated with high-density lipoprotein (HDL) level and particle size in healthy adults. The purpose of this study was to evaluate the factors that contribute to the variation in plasma PLTP specific activity. Analysis of the specific activity of PLTP complexes in nine plasma samples from healthy adults revealed two clusters of inactive PLTP complexes with mean molecular weights (MW) of 342kDa and 146kDa. The large and small inactive PLTP complexes represented 52±8% (range 39-63%) and 8±8% (range 1-28%) of the plasma PLTP, respectively. Active PLTP complexes had a mean MW of 207kDa and constituted 40±6% (range 33-50%) of the plasma PLTP. The specific activity of active PLTP varied from 16 to 32μmol/μg/h. These data demonstrate for the first time the existence of small inactive plasma PLTP complexes. Variation in the amount of the two clusters of inactive PLTP complexes and the specific activity of the active PLTP contribute to the variation in plasma PLTP specific activity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3075333PMC
http://dx.doi.org/10.1016/j.bbalip.2011.02.001DOI Listing

Publication Analysis

Top Keywords

plasma pltp
28
specific activity
28
pltp complexes
24
pltp specific
20
pltp
17
inactive pltp
16
phospholipid transfer
12
contribute variation
12
variation plasma
12
active pltp
12

Similar Publications

Background: Lipids play a critical role in defense against sepsis. We sought to investigate gene expression and lipidomic patterns of lipid dysregulation in sepsis.

Methods: Data from four adult sepsis studies were analyzed and findings were investigated in two external datasets.

View Article and Find Full Text PDF

Effect of phospholipid transfer protein on plasma sphingosine-1-phosphate.

J Biol Chem

November 2024

Department of Cell Biology, SUNY Downstate Health Sciences University, Brooklyn, New York, USA; Molecular and Cellular Cardiology Program, VA New York Harbor Healthcare System, Brooklyn, New York, USA. Electronic address:

Article Synopsis
  • Plasma phospholipid transfer protein (PLTP) is linked to cardiovascular diseases and is thought to influence levels of sphingosine-1-phosphate (S1P), a lipid mediator found in high-density lipoprotein (HDL).
  • Research using knockout (KO) mice showed that both PLTP deficiency and double deficiency (with apoM) lead to a significant reduction in HDL and plasma S1P levels, with PLTP deficiency also lowering apoM levels.
  • The study concluded that PLTP does not act as a direct carrier for S1P, but its depletion or overexpression affects S1P levels dramatically due to changes in HDL.
View Article and Find Full Text PDF

Erythropoiesis-stimulating agents (ESAs) continue to be a significant threat to the integrity of human and equine sports. Besides conventional direct testing, monitoring the biomarkers associated with the effects of ESAs may provide a complementary approach via indirect detection to enhance doping control. In this study, we applied label-free proteomics to discover plasma protein biomarkers in Thoroughbred geldings after administration with a long-acting form of recombinant human erythropoietin (rhEPO), methoxy polyethylene glycol epoetin beta, Mircera.

View Article and Find Full Text PDF

CE9A215 (inotodiol), a lanostane-type oxysterol, mitigates LPS-induced sepsis through multifaceted mechanisms.

Eur J Pharmacol

October 2024

CARBOEXPERT Inc, Daejeon, 34134, Republic of Korea; Department of Food Science and Technology, Chungnam National University, Daejeon, 34134, Republic of Korea. Electronic address:

Article Synopsis
  • Dysregulated immune responses during infections can cause sepsis, leading to multiple organ dysfunction and highlighting the need for new treatment approaches.
  • CE9A215 (inotodiol), a compound derived from fungi, has shown potential anti-inflammatory effects by reducing pro-inflammatory cytokines in both cell cultures and animal models.
  • The study found that CE9A215 improved survival in mice with sepsis while promoting the clearance of harmful lipopolysaccharides by enhancing specific proteins associated with lipid transport, suggesting its potential as a new therapy for sepsis.
View Article and Find Full Text PDF

Background: Small-quantity lipid-based nutrient supplements (SQ-LNS) during pregnancy and postnatally were previously shown to improve high-density lipoprotein (HDL) cholesterol efflux capacity (CEC) and length in the children of supplemented mothers at 18 mo of age in the International Lipid-Based Nutrient Supplements (iLiNS) DYAD trial in Ghana. However, the effects of SQ-LNS on maternal HDL functionality during pregnancy are unknown.

Objective: The goal of this cross-sectional, secondary outcome analysis was to compare HDL function in mothers supplemented with SQ-LNS vs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!